Two of India’s most established pharmaceutical players, Pfizer India & Cipla, have announced their first-ever partnership for the Indian market. Under the strategic tie-up, Cipla will exclusively market & distribute four Pfizer brands across key therapy areas, while Pfizer continues to manufacture the medicines. The deal highlights a growing trend of global drugmakers partnering with Indian pharma firms to strengthen last-mile reach & expand patient access Ekta Batra explains how these alliances